Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
GnRH signaling pathway | R-HSA-168638 | map04912 | streptozocin | 64971 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 5155877 | None | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | 5155877 | None | drug-path |
Ribosome | R-HSA-5368277 | map03010 | 5155877 | None | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | 5155877 | None | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | 5155877 | None | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | 5155877 | None | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | 5155877 | None | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | 5155877 | None | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | 5155877 | None | drug-path |
Asthma | R-HSA-444620 | map05310 | 5155877 | None | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | 5155877 | None | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | 5155877 | None | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | 5155877 | None | drug-path |
B cell receptor signaling pathway | R-HSA-983705 | map04662 | enalapril | 5388962 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | enalapril | 5388962 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | methotrexate | 126941 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | methotrexate | 126941 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | methotrexate | 126941 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | methotrexate | 126941 | drug-path |